| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 3.96M | $13.1M | $3.31 | 10 Nov 2021 | Indirect |
| Fulcrum Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 75.8K | $251K | $3.31 | 10 Nov 2021 | Direct |
| Fulcrum Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 15K | 09 Jun 2021 | Direct | ||
| Voyager Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 15K | 03 Jun 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics, Inc. | 10 Nov 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 12 Nov 2021, 16:31 |
| FULC | Fulcrum Therapeutics, Inc. | 22 Sep 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 24 Sep 2021, 16:13 |
| FULC | Fulcrum Therapeutics, Inc. | 09 Jun 2021 | 1 | $0 | 4 | Director | 11 Jun 2021, 17:11 |
| VYGR | Voyager Therapeutics, Inc. | 03 Jun 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 04 Jun 2021, 16:32 |